{"id":"duowell","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Duowell®","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:14:12.502304+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:14:21.028445+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Duowell®","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:14:22.695967+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T00:40:22.356Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:14:25.110034+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT03474562","phase":"PHASE4","title":"High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-04-03","conditions":"ASCVD, Impaired Fasting Glucose, Hypertension","enrollment":100},{"nctId":"NCT03267329","phase":"PHASE4","title":"Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-09-11","conditions":"Hypertension, Dyslipidemia","enrollment":80},{"nctId":"NCT02968160","phase":"PHASE4","title":"A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome","status":"TERMINATED","sponsor":"Yuhan Corporation","startDate":"2016-10","conditions":"Metabolic Syndrome","enrollment":55}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Duowell®","genericName":"Duowell®","companyName":"Yuhan Corporation","companyId":"yuhan-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:14:25.110034+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}